Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study

AIMS: To describe heparin dosing requirements in patients who underwent catheter ablation of atrial fibrillation with uninterrupted anticoagulation using dabigatran etexilate (dabigatran) or warfarin to attain therapeutic activated clotting time (ACT) in the RE-CIRCUIT(®) study. The RE-CIRCUIT study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Europace
Main Authors: Calkins, Hugh, Willems, Stephan, Verma, Atul, Schilling, Richard, Hohnloser, Stefan H, Okumura, Ken, Nordaby, Matias, Kleine, Eva, Bis, Branislav, Gerstenfeld, Edward P
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781146/
https://ncbi.nlm.nih.gov/pubmed/30982849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/europace/euz057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados